Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Other Accumulated Expenses (2020 - 2022)

Historic Other Accumulated Expenses for SOPHiA GENETICS (SOPH) over the last 3 years, with Q1 2022 value amounting to $12000.0.

  • SOPHiA GENETICS's Other Accumulated Expenses changed N/A to $12000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2021, which is 7500.0% down from last year.
  • Latest data reveals that SOPHiA GENETICS reported Other Accumulated Expenses of $12000.0 as of Q1 2022.
  • In the past 5 years, SOPHiA GENETICS's Other Accumulated Expenses ranged from a high of $2.9 million in Q2 2021 and a low of $12000.0 during Q4 2021
  • Its 3-year average for Other Accumulated Expenses is $631600.0, with a median of $48000.0 in 2020.
  • Over the last 5 years, SOPHiA GENETICS's Other Accumulated Expenses had its largest YoY gain of 7500.0% in 2021, and its largest YoY loss of 7500.0% in 2021.
  • SOPHiA GENETICS's Other Accumulated Expenses (Quarter) stood at $48000.0 in 2020, then crashed by 75.0% to $12000.0 in 2021, then changed by 0.0% to $12000.0 in 2022.
  • Its Other Accumulated Expenses was $12000.0 in Q1 2022, compared to $12000.0 in Q4 2021 and $227000.0 in Q3 2021.